KR960010002A - L-카르니틴염과 이를 함유한 피부질환 치료용 화장품 조성물 및 약제 조성물 - Google Patents

L-카르니틴염과 이를 함유한 피부질환 치료용 화장품 조성물 및 약제 조성물 Download PDF

Info

Publication number
KR960010002A
KR960010002A KR1019950019891A KR19950019891A KR960010002A KR 960010002 A KR960010002 A KR 960010002A KR 1019950019891 A KR1019950019891 A KR 1019950019891A KR 19950019891 A KR19950019891 A KR 19950019891A KR 960010002 A KR960010002 A KR 960010002A
Authority
KR
South Korea
Prior art keywords
pharmaceutical composition
carnitine
structural formula
composition according
represented
Prior art date
Application number
KR1019950019891A
Other languages
English (en)
Other versions
KR100366200B1 (ko
Inventor
클라우디오 카바자
파올로 카바자
Original Assignee
알도 파시
아방가르드 에스.피.에이.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 알도 파시, 아방가르드 에스.피.에이. filed Critical 알도 파시
Publication of KR960010002A publication Critical patent/KR960010002A/ko
Application granted granted Critical
Publication of KR100366200B1 publication Critical patent/KR100366200B1/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/22—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated the carbon skeleton being further substituted by oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/362—Polycarboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/006—Antidandruff preparations

Abstract

본 발명은 다음 구조식(Ⅰ)로 표시되는 신규 L-카르니틴염과 이를 함유한 피부질환 치료용 화장품 조성물 및 약제조성물에 관한 것으로서, 더욱 상세하게는 피부질환 치료를 위한 국소투여에 적합한 화장품 및 약제조성물의 유효성분으로서 신규 L-카르니틴염의 용도에 관한 것이다.
@ (Ⅰ)

Description

L-카르니틴염과 이를 함유한 피부질환 치료용 화장품 조성물 및 약제조성물
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (8)

  1. 다음 구조식(Ⅰ)로 표시되는 L-카르니틴산 아젤레이트
    @ (Ⅰ)
  2. 다음 구조식(Ⅰ)로 표시되는 L-카르니틴산 아젤레이트를 유효성분으로 하고 약제학적으로 수용가능한 부형제로 이루어진 것을 특징으로 하는 피부질환 치료를 위한 국소투여에 적합한 약제조성물
    @ (Ⅰ)
  3. 제2항에 있어서, 상기 약제조성물은 어린선 및 건선의 치료에 사용되는 것을 특징으로 하는 약제조성물
  4. 제2항에 있어서, 상기 약제조성물은 각화결손에 의한 피부병 치료에 사용되는 것을 특징으로 하는 약제조성물
  5. 제4항에 있어서, 상기 각화결손에 의한 피부병으로는 비듬, 여드름, 손바닥각화증 또는 발바닥 각화증인 것을 특징으로 하는 약제조성물
  6. 제2항에 있어서, 상기 약제조성물은 용액, 로션, 연고 또는 크림 형태임을 특징으로 하는 약제조성물
  7. 제6항에 있어서, 상기 약제조성물은 상기 구조식(Ⅰ)로 표시되는 L-카르니틴산 아젤레이트를 0.01∼20중량% 함유하는 것을 특징으로 하는 약제조성물
  8. 다음 구조식(Ⅰ)로 표시되는 L-카르니틴산 아젤레이트를 유효성분으로 하고 화장품 제제학적으로 수용가능한 부형제로 이루어진 것을 특징으로 하는 화장품 조성물
    @ (Ⅰ)
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019950019891A 1994-09-08 1995-07-07 L-카르니틴염과이를함유한피부질환치료용화장품조성물및약제조성물 KR100366200B1 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITRM94A000570 1994-09-08
ITRM940570A IT1274156B (it) 1994-09-08 1994-09-08 "sale della l-carnitina e composizioni farmaceutiche che lo contengonoper il trattamento di affezioni cutanee"

Publications (2)

Publication Number Publication Date
KR960010002A true KR960010002A (ko) 1996-04-20
KR100366200B1 KR100366200B1 (ko) 2003-03-03

Family

ID=11402717

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019950019891A KR100366200B1 (ko) 1994-09-08 1995-07-07 L-카르니틴염과이를함유한피부질환치료용화장품조성물및약제조성물

Country Status (14)

Country Link
US (1) US5637305A (ko)
EP (1) EP0700898B1 (ko)
JP (1) JP3831431B2 (ko)
KR (1) KR100366200B1 (ko)
AT (1) ATE160561T1 (ko)
CA (1) CA2157836C (ko)
DE (1) DE69501105T2 (ko)
DK (1) DK0700898T3 (ko)
ES (1) ES2111355T3 (ko)
GR (1) GR3026086T3 (ko)
HK (1) HK1004917A1 (ko)
IT (1) IT1274156B (ko)
PH (1) PH31607A (ko)
ZA (1) ZA957507B (ko)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1274156B (it) * 1994-09-08 1997-07-15 Avantgarde Spa "sale della l-carnitina e composizioni farmaceutiche che lo contengonoper il trattamento di affezioni cutanee"
IT1276253B1 (it) 1995-12-15 1997-10-27 Sigma Tau Ind Farmaceuti Composizione farmaceutica contenente l-carnitina o alcanoil l-carnitine per la prevenzione ed il trattamento di stati morbosi
IT1291113B1 (it) * 1997-03-20 1998-12-29 Sigma Tau Ind Farmaceuti Composizione nutritiva terapeutica per soggetti affetti da diabete mellito
US6090848A (en) * 1997-12-01 2000-07-18 Sigma-Tau Healthscience S.P.A. Compositions and methods for increasing the concentration and/or motility of spermatozoa in humans
US5863940A (en) 1997-12-01 1999-01-26 Sigma-Tau Healthscience S.P.A. Medicament and therapeutical method for treating idiopathic asthenozoospermia
PT951909E (pt) 1998-03-19 2004-04-30 Sigma Tau Ind Farmaceuti Composicao combinada que contem uma l-carnitina ou uma alcanoil-l-carnitina um glicosaminoglicano e/ou um seu constituinte
US6475965B2 (en) * 1999-12-28 2002-11-05 Colgate-Palmolive Company Skin moisturizing composition comprising a choline salt
US6265364B1 (en) * 1999-12-28 2001-07-24 Colgate-Palmolive Company Solid cleansing composition comprising a choline salt
US6372791B1 (en) 2000-06-29 2002-04-16 Johnson & Johnson Consumer Companies, Inc. Method of promoting skin cell metabolism
US6649176B1 (en) 2000-06-29 2003-11-18 Johnson & Johnson Consumer Companies, Inc. Compositions containing mineral water
US6432424B1 (en) 2000-06-29 2002-08-13 Johnson & Johnson Consumer Companies, Inc. Cosmetic compositions containing creatine, carnitine, and/or pyruvic acid
US6630175B1 (en) 2000-06-29 2003-10-07 Johnson & Johnson Consumer Companies, Inc. Method of reducing eye irritation
WO2006074379A2 (en) * 2005-01-07 2006-07-13 Azaya Therapeutics, Inc. Methods and compositions involving esters of azelaic acid and other dicarboxylic acids
EA017935B1 (ru) 2006-05-19 2013-04-30 Мэри Кэй Инк. Композиция для ухода за кожей и ее применение
JP5951277B2 (ja) * 2012-02-17 2016-07-13 ロート製薬株式会社 アゼライン酸を含有する外用組成物
KR102158895B1 (ko) 2013-03-12 2020-09-22 마리 케이 인코포레이티드 보존 시스템
FR3090347B1 (fr) * 2018-12-20 2020-12-18 Oreal Procédé de traitement des fibres kératiniques mettant en œuvre une composition comprenant un sel de carnitine ou de dérivé de carnitine comprenant un anion d’acide dicarboxylique aliphatique
CN112250588B (zh) * 2020-11-06 2023-03-31 哈尔滨工业大学（深圳） 一种左旋肉碱离子液体及其制备方法、应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1156840B (it) * 1978-06-27 1987-02-04 Sigma Tau Ind Farmaceuti Acil derivati della carnitina
FR2529545B1 (fr) * 1982-07-02 1985-05-31 Sanofi Sa Nouveaux sels de carnitine ainsi que leur procede de preparation
JP2529545Y2 (ja) * 1991-05-09 1997-03-19 シャープ株式会社 電子機器の組付け装置
IT1254135B (it) * 1992-01-16 1995-09-08 Sigma Tau Ind Farmaceuti Esteri di acil carnitine con alcooli alifatici a lunga catena e composizioni farmaceutiche che li contengono, ad attivita' antibatterica.
IT1263013B (it) * 1992-10-20 1996-07-23 Avantgarde Spa Esteri della l-carnitina e di alcanoil l-carnitine con l'acido glicolico o suoi esteri e composizioni farmaceutiche contenenti tali per il trattamento di affezioni cutanee.
IT1274156B (it) * 1994-09-08 1997-07-15 Avantgarde Spa "sale della l-carnitina e composizioni farmaceutiche che lo contengonoper il trattamento di affezioni cutanee"

Also Published As

Publication number Publication date
IT1274156B (it) 1997-07-15
JPH0892180A (ja) 1996-04-09
ITRM940570A1 (it) 1996-03-08
US5637305A (en) 1997-06-10
KR100366200B1 (ko) 2003-03-03
DE69501105D1 (de) 1998-01-08
PH31607A (en) 1998-11-03
HK1004917A1 (en) 1998-12-11
CA2157836A1 (en) 1996-03-09
CA2157836C (en) 2006-08-22
DK0700898T3 (da) 1998-08-10
ES2111355T3 (es) 1998-03-01
JP3831431B2 (ja) 2006-10-11
GR3026086T3 (en) 1998-05-29
ITRM940570A0 (it) 1994-09-08
DE69501105T2 (de) 1998-04-16
EP0700898A1 (en) 1996-03-13
ATE160561T1 (de) 1997-12-15
ZA957507B (en) 1996-04-18
EP0700898B1 (en) 1997-11-26

Similar Documents

Publication Publication Date Title
KR960000855A (ko) L-카르니틴염과 이를 함유한 피부질환 치료용 화장품 조성물 및 약제조성물
KR960010002A (ko) L-카르니틴염과 이를 함유한 피부질환 치료용 화장품 조성물 및 약제 조성물
US5153230A (en) Topical skin cream composition
US4707354A (en) Mature skin treatment and protectant compositions and methods of using same
US5425954A (en) Topical amino acid - vitamin complex compositions for pharmaceutical and cosmetic use
US20040102358A1 (en) Composition for treating skin conditions
US6248763B1 (en) Composition for treating skin conditions
US20060013845A1 (en) Oxygenated personal care products
US20070134175A1 (en) Panthenol and natural organic extracts for reducing skin irritation
KR880000091A (ko) 국소용 약제학적 조성물 이의 제조방법 및 이의 용도
WO2002030367A3 (en) Scalp cosmetic and dermatological compositions
JP2000503323A (ja) バクテリア、寄生虫、原生動物、菌・カビ及びウイルスに対して有効なスフィンゴ脂質
KR950000142A (ko) 피부질환치료용 약제조성물 제조에 사용되는 히드록시산함유 l-카르니틴에스테르 및 아실 l-카르니틴에스테르의 용도
KR900017590A (ko) 좌창(Acne)치료방법 및 그 약제 조성물
JP2993943B2 (ja) ホスホン酸誘導体とメタ二亜硫酸塩に基づくアスコルビン酸安定化のための安定剤とそれを含有する組成物
DE19634019A1 (de) Gegen Mikroogranismen, Viren, Parasiten und Protozoen wirksame Glycoglycerolipide
DK284386D0 (da) Farmaceutisk praeparat mod hudlidelser
EP0219455A3 (en) Pharmaceutical and cosmetic compositions containing n-acetylcysteine
KR960010003A (ko) L-카르니틴염과 이를 함유한 피부질환 치료용 화장품 조성물 및 약제 조성물
EP1172084A2 (de) Kosmetische und dermatologische Zubereitung zur Beseitigung vom Sebum
RU2282435C2 (ru) Фармацевтический состав для профилактики или лечения себореи, способ профилактики или лечения себореи.
JPH09175991A (ja) 尿酸およびウリカーゼを活性を示す含量で含む化粧品および皮膚科用組成物
ATE88995T1 (de) Urethan-derivate, ihre herstellung und verwendung als hautbefeuchtendes mittel in kosmetischen und pharmazeutischen zubereitungen zur behandlung trockener haut.
JPH02292215A (ja) 外用薬剤およびその使用方法
BR0016959A (pt) Agente fisiologicamente ativo com ditio glicol vicinal e seu uso em diversos setores da economia

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20111128

Year of fee payment: 10

FPAY Annual fee payment

Payment date: 20121127

Year of fee payment: 11

LAPS Lapse due to unpaid annual fee